Biomarkers and antibiotic treatment of exacerbations of COPD

Oral Presentation
Chairs: M. Miravitlles (Barcelona, Spain), T. Wilkinson (Timsbury, United Kingdom)
Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease
A. Lacoma, C. Prat, J. Domínguez, F. Andreo, S. Blanco, M. A. Cuesta, J. Ruiz-Manzano, V. Ausina (Badalona, Madrid, Spain)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease
A. Lacoma, C. Prat, J. Domínguez, F. Andreo, S. Blanco, M. A. Cuesta, J. Ruiz-Manzano, V. Ausina (Badalona, Madrid, Spain)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
The role of bacterial pathogens in exacerbation of COPD assessed by microbiological method and polymerase chain reaction
K. Kolosova, O. Tsvetkova, E. Ilina, M. Atroshkina (Moscow, Russian Federation)
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
The relation of sputum color to bacterial load in exacerbations of COPD
M. Brusse-Keizer, A. Grotenhuis, H. Kerstjens, M. Telgen, J. van der Palen, R. Hendrix, P. van der Valk (Enschede, Groningen, Netherlands)
Congress or journal article abstractE-posterSlide presentation
Congress or journal article abstractE-posterSlide presentation
Prulifloxacin in the treatment of acute exacerbations of COPD (AECOPD) in cigarette smokers
G. Biscione, G. Crigna, F. Pasqua, M. Cazzola (Velletri, Rome, Rome, Italy)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Analysis of the efficacy of moxifloxacin for the treatment of bronchial colonization in COPD patients using microbial molecular typing: a randomized, double-blind, placebo-controlled study
A. Marin-Tapia, E. Monsó, L. Millares, M. García, M. Miravitlles, C. de la Roza, R. Hervás, S. Vila, C. Esquinas, A. Torres, J. Morera (Badalona, Barcelona, Spain)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Clinical significance of aspergillus isolation from respiratory samples in severe COPD patients. Usefulness of Ascioglu‘s criteria
M. Sancho, M. Gallego, C. Monton, D. Mariscal, A. Moreno, X. Pomares, A. Marin (Sabadell (Barcelona), Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
E. Hagiwara, A. Sekine, T. Sato, T. Baba, T. Shinohara, T. Endo, Y. Sogo, R. Nishihira, S. Komatsu, Y. Matsumoto, T. Ogura, H. Takahashi (Yokohama, Japan)
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster